Synaptogenix, Inc.
SNPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,281 | $3,169 | $7,917 | $42,550 |
| - Cash | $17,656 | $28,661 | $37,478 | $34,214 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$13,375 | -$25,492 | -$29,561 | $8,336 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$6 | -$6 | -$6 | -$5 |
| % Margin | – | – | – | – |
| EBITDA | -$12,763 | -$8,308 | -$16,129 | -$12,613 |
| % Margin | – | – | – | – |
| Net Income | -$12,769 | -$6,039 | -$5,458 | -$12,604 |
| % Margin | – | – | – | – |
| EPS Diluted | -10.99 | -29.56 | -20.35 | -62.87 |
| % Growth | 62.8% | -45.3% | 67.6% | – |
| Operating Cash Flow | -$4,884 | -$5,173 | -$11,211 | -$8,711 |
| Capital Expenditures | $0 | -$3 | -$7 | -$3 |
| Free Cash Flow | -$4,884 | -$5,176 | -$11,219 | -$8,714 |